Tipranavir//Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine//Naloxone

Author： Bruce R. Douglas   Moody David E.   Fang Wenfang B.   Chodkowski Diane   Andrews Laurie   Friedland Gerald H.  

Publisher： Informa Healthcare

ISSN： 0095-2990

Source： The American Journal of Drug and Alcohol Abuse, Vol.37, Iss.4, 2011-07, pp. : 224-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment

By Douglas Bruce R.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 80-85

Informa Healthcare

Access to resources Recommend Favorite

Buprenorphine/naloxone reduces drug abuse, costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 552, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

By Orman Jennifer S.   Keating Gillian M.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 899-902

Adis International

Access to resources Recommend Favorite

Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review

By  

Current Drug Abuse Reviews, Vol. 4, Iss. 1, 2011-03 ,pp. : 28-41

Bentham Science Publishers

Access to resources Recommend Favorite

Buprenorphine and Naloxone Combinations and Dopamine

By  

Current Psychopharmacology, Vol. 6, Iss. 2, 2018-01 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite